8-Hydroxyquinoline → HCID 66807170, Verbindung

HRID 1843995Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1843995
CC1C=CN=CC=1N1C=CC2NC3C=CC=CC=3C=2C1=O.[C:22]1(=[O:35])[C:34]2[C:33]3[CH:32]=[CH:31][CH:30]=[CH:29][C:28]=3[NH:27][C:26]=2[CH:25]=[CH:24][NH:23]1.Br[C:37]1[CH:38]=[N:39][CH:40]=[CH:41][C:42]=1[C:43]([F:46])([F:45])[F:44].OC1C=CC=C2C=1N=CC=C2.C([O-])([O-])=O.[K+].[K+]>[Cu](I)I.CS(C)=O>[F:44][C:43]([F:46])([F:45])[C:42]1[CH:41]=[CH:40][N:39]=[CH:38][C:37]=1[N:23]1[CH:24]=[CH:25][C:26]2[NH:27][C:28]3[CH:29]=[CH:30][CH:31]=[CH:32][C:33]=3[C:34]=2[C:22]1=[O:35]

Komponenten

8

Versuchsvorschrift

Using analogous reaction conditions and work up as described for the preparation of 62A above, 2,5-dihydro-1H-pyrido[4,3-b]indol-1-one (I-62a: 200 mg, 1.08 mmol) was reacted with 3-bromo-4-trifluoromethylpyridine (368.4 mg, 1.63 mmol), 8-hydroxy quinoline (31.3 mg, 0.216 mmol), K2CO3 (223.5 mg, 1.62 mmol), copper iodide (41.14 mg, 0.216 mmol) and DMSO (5 mL) to afford the crude product. Purification by column chromatography on silica gel (2% methanol in DCM), followed by preparative HPLC afforded 5 mg of the product (1.5% yield).

Aufarbeitung

  1. customreaction conditions
  2. customto afford the crude product
  3. customPurification by column chromatography on silica gel (2% methanol in DCM)

Quellen und Nachweise

ORD-Eintrag
ord-7adf1c703b604a279a221433260b2f0a
Quelldatensatz
uspto-grants-2015_02
Patentnummer
US08946260B2

Notizen zur Reaktion

Wird geladen…